We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLDB icon
3251
Solid Biosciences
SLDB
$961M
$18.5K ﹤0.01%
4,636
+2,848
+159% +$15.6K
WLKP icon
3252
Westlake Chemical Partners
WLKP
$762M
$18.5K ﹤0.01%
801
+271
+51% +$6.22K
WNS
3253
DELISTED
WNS Holdings
WNS
$18.5K ﹤0.01%
390
-1,172
-75% -$57.8K
GRWG icon
3254
GrowGeneration
GRWG
$105M
$18.5K ﹤0.01%
10,923
+7,458
+215% +$14.3K
ALNT icon
3255
Allient
ALNT
$1.88B
$18.4K ﹤0.01%
759
-372
-33% -$8.21K
BCAX
3256
Bicara Therapeutics
BCAX
$1.58B
$18.4K ﹤0.01%
+1,056
New +$22K
ZUMZ icon
3257
Zumiez
ZUMZ
$317M
$18.4K ﹤0.01%
958
-7,293
-88% -$156K
RAPT
3258
DELISTED
RAPT Therapeutics
RAPT
$18.4K ﹤0.01%
1,452
+791
+120% +$10K
TCBX icon
3259
Third Coast Bancshares
TCBX
$768M
$18.3K ﹤0.01%
539
-3,513
-87% -$114K
ITOS
3260
DELISTED
iTeos Therapeutics
ITOS
$18.3K ﹤0.01%
2,382
-2,788
-54% -$24K
ULCC icon
3261
Frontier Group Holdings
ULCC
$1.56B
$18.3K ﹤0.01%
2,570
-15,694
-86% -$97.9K
BTSG icon
3262
BrightSpring Health Services
BTSG
$12.1B
$18.3K ﹤0.01%
1,072
-1,040
-49% -$18K
DOMO icon
3263
Domo
DOMO
$184M
$18.3K ﹤0.01%
2,578
+872
+51% +$7.06K
EWC icon
3264
iShares MSCI Canada ETF
EWC
$6.55B
$18.2K ﹤0.01%
452
+433
+2,279% +$18.1K
CATX icon
3265
Perspective Therapeutics
CATX
$357M
$18.2K ﹤0.01%
5,709
+3,509
+160% +$28.6K
CURE icon
3266
Direxion Daily Healthcare Bull 3X ETF
CURE
$186M
$18.2K ﹤0.01%
197
-390
-66% -$43.9K
PROK icon
3267
ProKidney
PROK
$279M
$18.2K ﹤0.01%
10,757
+5,658
+111% +$10.2K
HCM icon
3268
HUTCHMED
HCM
$2.12B
$18.2K ﹤0.01%
1,261
-2,234
-64% -$39.9K
LTBR icon
3269
Lightbridge
LTBR
$321M
$18.2K ﹤0.01%
3,841
+2,312
+151% +$13.8K
AFCG
3270
AFC Gamma
AFCG
$71.2M
$18.1K ﹤0.01%
2,178
-103
-5% -$989
SGMA
3271
DELISTED
Sigmatron International
SGMA
$18.1K ﹤0.01%
10,177
+3,517
+53% +$9.17K
AOMR
3272
Angel Oak Mortgage REIT
AOMR
$209M
$18.1K ﹤0.01%
1,950
+81
+4% +$775
CLBK icon
3273
Columbia Financial
CLBK
$1.22B
$18K ﹤0.01%
1,141
-320
-22% -$5.51K
NIXX
3274
Nixxy Inc
NIXX
$19.9M
$18K ﹤0.01%
3,427
+2,083
+155% +$6.91K
ATAI icon
3275
AtaiBeckley Inc
ATAI
$2.69B
$18K ﹤0.01%
13,549
+1,274
+10% +$1.69K

Similar funds

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.